Atlas Trials

A Clinical Study Investigating Rifampicin and Dolutegravir in Combination in Healthy Volunteers

Clinical trial NCT03199690 · UNKNOWN

Trial details

NCT number
NCT03199690
Sponsor
St. Stephens Clinical Research
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
HIV-1-infectionTuberculosis
Start date
2017-10-01
Primary completion
2018-03-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.